Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
Chr amplification(1)(q21)
Associations
(6)
News
Trials
B | Sensitive
C3 | Sensitive
D | Sensitive
B | Resistant
C3 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
Immunotherapy
Interleukins
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Other
BCL Inhibitors
Cancel
Multiple Myeloma
pomalidomide + isatuximab-irfc
B
Chr amplification(1)(q21)
|
Multiple Myeloma
|
pomalidomide + isatuximab-irfc
lenalidomide + isatuximab-irfc
B
Chr amplification(1)(q21)
|
Multiple Myeloma
|
lenalidomide + isatuximab-irfc
Isa-KRd
C3
Chr amplification(1)(q21)
|
Multiple Myeloma
|
Isa-KRd
ARRY-520
C3
Chr amplification(1)(q21)
|
Multiple Myeloma
|
ARRY-520
thalidomide
C3
Chr amplification(1)(q21)
|
Multiple Myeloma
|
thalidomide
lenalidomide + APG-2575
D
Chr amplification(1)(q21)
|
Multiple Myeloma
|
lenalidomide + APG-2575
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login